ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
4,967.23
-0.88%
US Tech 100
16,588.00
-2.06%
Dow Jones
37,986.40
0.56%
Brent Oil
86.645
0.27%
Bitcoin
63,877.04
0.58%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. OSE Immunotherapeutics (OSE) Quote

OSE Immunotherapeutics

OSE Immunotherapeutics (OSE)

EU
5.38
0.38
(7.60%)
Closed April 19 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
5.38
Bid
5.36
Ask
5.41
Volume
328,456
4.95 Day's Range 5.49
2.705 52 Week Range 7.31
Market Cap
116.483M
Previous Close
5.00
Open
4.96
Last Trade
1
@
5.38
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
125,936
Shares Outstanding
21,651,101
Dividend Yield
-
PE Ratio
-5.06
Earnings Per Share (EPS)
-1.06
Revenue
2.23M
Net Profit
-23M

About OSE Immunotherapeutics

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.ose-immuno.com
Headquarters
Nantes, Loire-atlantique, Fra
Founded
1970
OSE Immunotherapeutics is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker OSE. The last closing price for OSE Immunotherapeutics was 5.00 €. Over the last year, OSE Immunotherapeutics shares have traded in a share price range of 2.705 € to 7.31 €.

OSE Immunotherapeutics currently has 21,651,101 shares outstanding. The market capitalization of OSE Immunotherapeutics is 116.48 € million. OSE Immunotherapeutics has a price to earnings ratio (PE ratio) of -5.06.

OSE Latest News

More News

OSE Immunotherapeutics annonce l’entrée en vigueur de la licence mondiale pour développer un anticorps monoclonal innovant dans le traitement de l’inflammation chronique

OSE Immunotherapeutics annonce l’entrée en vigueur de la licence mondiale pour développer un anticorps monoclonal innovant dans le traitement de l’inflammation chronique OSE...

April 16 2024
GlobeNewswire Inc.

OSE Immunotherapeutics reçoit un financement public de 8,4 M€ pour soutenir l’essai clinique de Phase 3 d’enregistrement du vaccin Tedopi® contre le cancer du poumon

OSE Immunotherapeutics reçoit un financement public de 8,4 M€ pour soutenir l’essai clinique de Phase 3 d’enregistrement du vaccin Tedopi® contre le cancer du poumon OSE Immunotherapeutics...

April 10 2024
GlobeNewswire Inc.

OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer

OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer OSE Immunotherapeutics Receives €8.4 M...

April 10 2024
GlobeNewswire Inc.

Informations relatives au nombre total de droits de vote et d’actions composant le capital

Informations relatives au nombre total de droits de vote et d’actions composant le capital Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes...

April 03 2024
GlobeNewswire Inc.

OSE Immunotherapeutics annonce une publication sur CLEC-1, point de contrôle immunitaire innovant, dans la revue à Comité de lecture Journal of Immunology

OSE Immunotherapeutics annonce une publication sur CLEC-1, point de contrôle immunitaire innovant, dans la revue à Comité de lecture Journal of Immunology OSE Immunotherapeutics annonce une...

April 02 2024
GlobeNewswire Inc.

OSE Immunotherapeutics publie ses résultats financiers annuels 2023 et fait le point sur sa stratégie de développement

OSE Immunotherapeutics publie ses résultats financiers annuels 2023 et fait le point sur sa stratégie de développement OSE Immunotherapeutics publie ses résultats financiers annuels 2023 et...

March 27 2024
GlobeNewswire Inc.

OSE Immunotherapeutics annonce la fin du recrutement dans l’étude clinique de Phase 2 de Lusvertikimab évalué chez des patients souffrant de rectocolite hémorragique

Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) annonce aujourd’hui la fin du recrutement dans l’essai clinique de Phase 2b évaluant l’anticorps monoclonal...

March 18 2024
Business Wire

OSE Immunotherapeutics : Informations relatives au nombre total de droits de vote et d’actions composant le capital

Regulatory News: En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE...

March 01 2024
Business Wire

OSE Immunotherapeutics organise un Webinaire pour commenter l’accord mondial conclu avec AbbVie le 28 février 2024 à 18 heures

Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), organise un Webinaire le 28 février 2024 à 18 heures pour commenter l’accord mondial de collaboration et de licence...

February 28 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.67514.34643995754.7055.494.5051051734.8449636DE
40.6213.0252100844.765.494.5051003794.88514408DE
121.5339.74025974033.8563.1151259364.76210633DE
261.02523.53616532724.35563.1151091014.51396747DE
520.3857.707707707714.9957.312.7051421624.70081916DE
156-6.62-55.16666666671213.682.705799406.38980858DE
2601.3834.5415.82.705745397.24556166DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OLBOLB Group Inc
$ 0.5801
(75.79%)
441.92k
CSLRComplete Solaria Inc
$ 0.80
(71.93%)
3.41M
MNDRMobile health Network Solutions
$ 31.50
(15.64%)
155.42k
GDHGGolden Heaven Group Holdings Ltd
$ 0.27
(14.80%)
1.69M
ARBBARB IOT Group Ltd
$ 1.32
(11.87%)
7.7k
WRNTWarrantee Inc
$ 0.391
(-18.37%)
201
SOBRSOBR Safe Inc
$ 0.2305
(-11.35%)
6.8k
CRMLCritical Metals Corporation
$ 7.85
(-10.69%)
728
VAXXVaxxinity Inc
$ 0.4251
(-10.35%)
10.86k
SGDSafe and Green Development Corporation
$ 0.6397
(-9.90%)
1.16k
CSLRComplete Solaria Inc
$ 0.80
(71.93%)
3.41M
INTCIntel Corporation
$ 34.19
(0.00%)
1.88M
GDHGGolden Heaven Group Holdings Ltd
$ 0.27
(14.80%)
1.69M
GRABGrab Holdings Ltd
$ 3.37
(0.30%)
1.54M
NKTRNektar Therapeutics
$ 1.24
(-0.80%)
1.47M

Discussion

View Full Feed
money-maker money-maker 17 seconds ago
Told you
PRDL
bunda bunda 18 seconds ago
let me add you to the ignore list too
IGPK
janice shell janice shell 25 seconds ago
As you say, it seems to include commentary on much of what he's seen on TV or in movies recently, or perhaps going back decades. I wonder how old he is.
ZenNavigator54 ZenNavigator54 49 seconds ago
THE ""OFFICIAL"" COMMITTEE OF UNSECURED CREDITORS OF HUMANIGEN, INC is a fake committee comprised of fake creditors. 40 million of the 44 million 'claims' were fake and fraudulent creditor cliams and is 'disputed' claims.
The real owner of this company created these fake creditors so it can
HGENQ
Sssantino3737 Sssantino3737 1 minute ago
Believe in June I think
EGOX
TenKay TenKay 1 minute ago
What filing did they make that was a lie? Give me just one. They always couched things in a way that if push came to shove they had deniability. The gullible shareholders stuck their head into the sand and used their imaginations to conjure up nonsense. That is on the gullible shareholder.
GNCP
AlwaysOptimistic AlwaysOptimistic 1 minute ago
I agree ge. Transparency is good. Go NioCorp!
NB
AlwaysOptimistic AlwaysOptimistic 1 minute ago
I agree ge. Transparency is good. Go NioCorp!
NB
bunda bunda 2 minutes ago
when you stop with yours
TONR
otcsource otcsource 2 minutes ago
The industry is down! Do the Research. So why is it that KEGS cannot file financials properly? Since as you say they have so much going for themselves?
KEGS
Flobewan Flobewan 2 minutes ago
Wowza, was just catching up, what a way to go.
newmedman newmedman 2 minutes ago
I've supported the dark carnival for over 30 years lol I never knew we had real clowns.

[yt]r2uzYJGNp7M[/yt]
StayHumble StayHumble 2 minutes ago
w0wSEC🔥charges🎅🏿&👽w/ArtificiallyDeflatingSharePricestoBuy Shares at a cheaper price

6, 12, 2023 —
SEC charged investment adviser Sabby Management LLC & managing partner,Hal D. Mintz,w/ fraud in connection w/ a long running scheme involving misrep
DBMM GTII HCMC
Abig Abig 2 minutes ago
NDR what don't you understand? They didn't need LWLG back then they were happy adding transistors into the integrated circuits to go faster with more data.
Well Moore's law hit a wall they cannot go faster without greater expense and energy. They have no choice they need to change their appro
LWLG
janice shell janice shell 2 minutes ago
Great idea!
Squirrel Hunter Squirrel Hunter 2 minutes ago
Big volume yesterday. Something must be up. Or maybe a Doctor who really likes the tests?
AXIM
sspalmo sspalmo 3 minutes ago
Take a second and let this load. You may see what the rest of us are seeing.
https://mab.tech/
ENZC
fuagf fuagf 3 minutes ago
That Sam's conspiracy theory leaves little out. As in many there is probably some truth in it. Dragging in The Simpson's feels a bit much.
BluePineCapital BluePineCapital 4 minutes ago
This won’t go anywhere without a split
GSTC
BullNBear52 BullNBear52 4 minutes ago
Nunes should hire Rudy as the corporate spokesman.
NorfolkIP NorfolkIP 4 minutes ago
You bet, Frank. Hasn’t always been smooth but I believe in the mission. Thanks for all you do.
CLNV
docsetc docsetc 4 minutes ago
New, low-cost recruit ?? LMAO....
ENZC
jac99 jac99 5 minutes ago
I have only been on this board for 2 weeks and have already set a personal record for “Ignore” status on posters.

And, according to some of you, I am not the only one.

Wow!
IGPK
ddls ddls 5 minutes ago
Do you plan on staying here after BIEL>closes up?
BIEL
Jess070283 Jess070283 5 minutes ago
Well I guess this was a flop. I guess I will just short to zero. Sounds like a free ATM….
SBFM

Your Recent History

EU
OSE
OSE Immunotherapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved